Fosicomp, Tabletten - 98 Tablette(n) |
| 52586038 | | Bristol-Myers Squibb SA | | Fosicomp, Tabletten | | 14.12.1995 | | | | 14.12.1995 | | Fosinopril and Diuretics (C09BA09) | | 23.12.2004 | | WHO-DDD | | 22.12.2019 | | 02.07.20. | | 98 Tablette(n) | | 02.07.20. | | | | B | | | | No | | | | IP | | CI | | 39.41 | | | | k.A. | | 61.65 | | FB | | | | 7680525860384 | | Synthetika human | | | | |
|
Composition |
fosinoprilum natricum 20 mg, hydrochlorothiazidum 12.5 mg, excipiens pro compresso. |
Packungsbestandteile |
| Tabletten | | | | Active Agent | Dose |
---|
Fosinoprilum Natricum | 20 mg | Hydrochlorothiazidum | 12.5 mg |
|
|
Source |
Data was imported : 04.12.2014
Swissmedic Registration : 52586
Sequence : 01
Product name : Fosicomp, Tabletten
Registration owner: : Bristol-Myers Squibb SA
Product group :
Index Therapeuticus (BSV) : 02.07.2.
Medication Code : Synthetika human
Date of registration : 14.12.1995
Valid until : 22.12.2019
Package number : 038
Show package size : 98
Commercial Form/Unit : Tablette(n)
Swissmedic categorie. : B
Active Agents : fosinoprilum natricum, hydrochlorothiazidum
Composition : fosinoprilum natricum 20 mg, hydrochlorothiazidum 12.5 mg, excipiens pro compresso.
|
|